ctrl K

Allena Pharmaceuticals In... (ALNA)

0.07

-0.00 (-3.71%)

At close: Sep 07, 2022, 8:00 PM

Allena Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-32.34M	-31.99M	-46.92M	-35.59M	-20.95M	-24.19M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-32.84M	-32.84M	-47.34M	-35.65M	-21.65M	-24.51M
Net Income	-33.35M	-32.84M	-47.34M	-35.65M	-21.65M	-24.51M
Selling & General & Admin	11.6M	11.6M	9.68M	9.22M	5.43M	4.08M
Research & Development	20.38M	20.38M	37.24M	26.38M	15.52M	20.1M
Other Expenses	n/a	n/a	605K	n/a	n/a	n/a
Operating Expenses	31.99M	31.99M	46.92M	35.59M	20.95M	24.19M
Interest Expense	510K	-510K	270K	575K	-443K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	576K	n/a	n/a
Cost & Expenses	31.99M	31.99M	46.92M	35.59M	20.95M	24.19M
Income Tax Expense	510K	-859K	-419K	-55K	-700K	-321K
Shares Outstanding (Basic)	32.51M	32.51M	22.18M	20.74M	4.52M	15.28M
Shares Outstanding (Diluted)	32.51M	32.51M	22.18M	20.74M	4.52M	15.28M
EPS (Basic)	-1.03	-1.01	-2.13	-1.72	-4.79	-1.6
EPS (Diluted)	-1.03	-1.01	-2.13	-1.72	-4.79	-1.6
EBITDA	-31.97M	-32.68M	-47.18M	-35.57M	-21.58M	-24.46M
EBIT	n/a	-33.35M	-47.49M	-35.07M	-22.09M	n/a
Depreciation & Amortization	363K	166K	163K	78K	73K	46K